• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A method and apparatus for selectively treating a targeted portion of internal body tissue of a patient by providing an internal electrode at a point adjacent the tissue to be treated and electrodes external to the patient's body. Fluid containing Ionic molecules is supplied to a location between the internal electrode and the external electrodes and an electric field radiating outwardly from the internal electrode to the external electrodes is created so that said fluid flows outwardly away from said internal electrode into the tissue to be treated.
    公开号:US20010001816A1
    申请号:US09/748,397
    申请日:2000-12-26
    公开日:2001-05-24
    发明作者:Andrew Feiring
    申请人:Feiring Andrew Jonathan；
    IPC主号:A61M25-104
    专利说明:
    [0001] The present invention relates to techniques and devices for inducing the permeation of medication and the like into body tissue and organs. [0001] BACKGROUND OF THE INVENTION
    [0002] Iontophoresis has been utilized for many years for delivering medication into the body of a patient to diagnose and treat various ailments. Another related procedure iontohydrokinesis has been proposed for similar use. For example, iontophoresis has been utilized to deliver Pilocarpine medication to diagnose cystic fibrosis, for the permeation of insulin through the skin, the introduction of steroids into joints to treat arthritis, to anesthetize the eardrum or eye, to treat plantar warts with sodium salicylate, to treat canker sores in the mouth with steroids, to treat Peyronie's disease (the fibrosing of the penis), and to deliver procainamide across the heart during experimental open chest surgery in dogs. [0002]
    [0003] Iontophoresis involves the transportation of medication in the form of naturally charged or ionic molecules by creating an electric field which acts as a driving force to cause the molecules to advance toward an oppositely charged pole. More particularly, iontophoresis is defined in [0003] Steadman's Medical Dictionary as the introduction by means of electric current of ions of soluble salts into the tissues of the body for therapeutic purposes; alternatively, the facilitated entry of electrically charged drugs into the surface tissue by application of an electric current. For example, if fluid having charged molecules is placed on a patient's skin and a properly oriented electric field is developed, the fluid will permeate the patient's skin. Where the molecules normally are uncharged, they may be rendered ionic by lowering or raising the pH of the carrying fluid.
    [0004] The principle is similar for iontohydrokinesis which may be used to deliver uncharged, non-polar molecules of medication. In iontohydrokinesis, water, which has naturally charged molecules and containing noncharged or non-polar molecules of medication, is transported into the tissue of a patient. By subjecting the mixture to an electrical field, the water molecules will carry the uncharged particles with them as they flow from one pole towards the other. [0004]
    [0005] Typically the technique for developing the electric field in iontophotesis or iontohydrokinesis involves placing both positive and negative electrodes externally of the patient's body or the specific organ that is to be treated. Consequently, the techniques do not lend themselves to targeted, localized treatment of internal body organs. [0005]
    [0006] Generally, when it has been desired to use the procedure locally on an internal organ, it has been necessary to expose the organ surgically. Once the organ is exposed, the electrodes can be placed on opposite sides of the organ, as in the case of the delivery of procainamide to the heart during open chest surgery, discussed above. Such a surgical technique for localized treatment of internal organs has obvious drawbacks such as trauma to the patient and other disadvantages and risks of general surgery. It would be desirable, therefore, to provide a less invasive technique for delivering an effective concentration of medication locally to an internal organ. For example, it would be desirable to deliver concentrations of selected compounds to the wall of an artery as an adjunct to angioplasty, procedure to enlarge a narrowed (stenosed) portion of an artery by placing a balloon in the stenosis and inflating the balloon to dilate the stenosis, thus improving blood flow through the artery. [0006]
    [0007] A significant problem in angioplasty is the relatively high rate of restenosis (approximately 30%) after performing an initial angioplasty. It has been suggested that restenosis may be controlled or possibly prevented by applying suitable medication to the wall of the artery in the region of the angioplasty. For example, among the factors thought to contribute to incidence of restenosis is the uncontrolled proliferation of smooth muscle cells in the arterial wall, as a consequence of the angioplasty. To that end, it has been proposed that a concentrated dose of suitable medication, such as heparin, be applied to a local region of an artery and forced into the wall of the artery under pressure. A catheter adopted for that purpose is disclosed in U.S. Pat. No. 4,636,195 issued Jan. 13, 1987 to Wolinsky. The Wolinsky patent describes a catheter having a pair of spaced balloons mounted on the distal end of the catheter. The catheter is inserted into the patient's arteries and is navigated to the site of the angioplasty. The catheter is positioned so that the balloons embrace the region of the angioplasty. Suitable medication, such as heparin, then is forced, under pressure, into the space between the inflated balloons to force the medication, under pressure, into the wall of the artery. [0007]
    [0008] It is among the objects of the invention, therefore, to provide a minimally evasive technique for delivering an effective concentration of medication or the like locally to an internal organ of the patient. [0008] SUMMARY OF THE INVENTION
    [0009] In accordance with the invention, medication or the like is cause to permeate through the tissue of a specific, targeted internal body organ using iontophoresis or iontohydrokinesis techniques. Practising the invention involves placing one or more electrodes externally of and circumferentially about the patient. Another electrode is inserted, as by a catheter, into the target organ or a selected portion of the organ. While an electric field is developed between the internal and external electrodes, medication having charged or polar molecules (iontophoresis) or uncharged molecules coupled with polar molecules, such as water (iontohydrokinesis), then may be delivered directly to the internal organ at a location between the internal and external electrodes. The electric field will cause the medication to permeate radially outwardly from the internal electrode toward the external electrodes thus causing the medication to permeate through the target organ. [0009]
    [0010] One embodiment of the invention adapted for use in treating the wall of a blood vessel or other body lumen employs a balloon catheter which may be placed in the blood vessel and positioned by inflating the balloon in the specific portion to be treated. The catheter carries an internal electrode which may be in the form of an insulated wire extending through the catheter and terminating in the exposed electrode inside the balloon. The balloon which also acts as a drug reservoir has a plurality of regularly spaced minute pores. The interior of the inflatable balloon is in communication with a source of liquid medication by a lumen that extends through the catheter from the proximal end where the lumen can be connected to the liquid source. Medication (ionic or coupled to a charged liquid molecule) is delivered to the balloon and weeps through the minute pores during generation of the electric field. When used adjacent the heart, the electric field may be pulsed on during systole to reduce the risk of inducing cardiac arrhythmia. [0010]
    [0011] It is among the objects of the invention to provide a method of inducing permeation of medication to a selected internal organ or body tissue. [0011]
    [0012] Another object of the invention is to provide a method for treating a body organ with a substantial concentration of medicine or drugs, without systematically exposing the patent to such a concentration. [0012]
    [0013] A further object of the invention is to provide a method and apparatus for permeating the wall of an artery with suitable medication so as to reduce the risk of restenosis after angioplasty as well as a primary treatment of obstructive coronary artery disease. [0013]
    [0014] Another object of the invention is to provide a selective medication delivery technique for internal organs using principles of iontophoresis and iontohydrokinesis. [0014]
    [0015] A further object of the invention is to utilize external electrodes and an electrode located in a targeted body organ for creating an electric field to induce the permeation of medication into the targeted body organ by iontophoresis or iontohydrokinesis. [0015] DESCRIPTION OF THE DRAWINGS
    [0016] The foregoing and other objects and advantages of the invention will be appreciated more fully from the further description thereof, with reference to the accompanying drawings wherein: [0016]
    [0017] FIG. 1 is a diagrammatic illustration of a system for practising one embodiment of the invention including a balloon catheter having a permeable balloon and a “driving” electrode, and an external “return” electrode; [0017]
    [0018] FIG. 2 is a cross-sectional illustration of the catheter shaft in a two lumen embodiment of the invention; [0018]
    [0019] FIG. 2A is a cross-sectional illustration of the shaft of the catheter in a three lumen embodiment of the invention in which the balloon is in communication with two lumens including an inlet lumen and a return lumen; [0019]
    [0020] FIG. 3 is an enlarged diagrammatic illustration of the catheter in accordance with the invention illustrating the balloon and electrode configuration at the distal end of the catheter; [0020]
    [0021] FIG. 3A is an illustration similar to FIG. 3 illustrating the distal end of the catheter or a three lumen device of the type illustrated in FIG. 2A; and [0021]
    [0022] FIG. 4 is a diagrammatic illustration of a patient having multiple electrodes placed circumferentially outside the body. [0022] DESCRIPTION OF THE PREFERRED EMBODIMENTS
    [0023] FIG. 1 illustrates apparatus as it may be used in the practice of the invention. The apparatus includes a catheter [0023] 10 and an external return electrode 12. Although only one external electrode 20 is illustrated in FIG. 1, multiple external electrodes preferably are employed and are placed circumferentially about the patient as illustrated in FIG. 4.
    [0024] As illustrated diagrammatically in FIG. 1, the catheter includes an elongate flexible shaft [0024] 12 that may be formed from any of a variety of polymeric materials commonly used in catheter manufacture. The catheter 10 has a proximal end (to the left in FIG. 1) that remains outside of the patient and a distal end (to the right in FIG. 1) that is inserted into the patient. An inflatable and deflatable balloon 14 is mounted to the distal end of the catheter shaft 12. The proximal end of the catheter shaft may branch out into two or three proximal legs including an inflation/deflation leg 16 and a guidewire leg 18 (in the two leg embodiment) and a third fluid return leg 20 (in the three leg embodiment). It should be noted that in the two leg embodiment, return leg 20 is omitted, all three legs 16, 18, 20 being shown in FIG. 1 for convenience of illustration. The catheter may have two or three lumens.
    [0025] FIG. 2 illustrates, diagrammatically, the cross-sectional configuration of the catheter shaft [0025] 12 in a two leg, two lumen embodiment. In this embodiment, the catheter shaft 12 includes an inflation lumen 22 and a guidewire lumen 24. The inflation lumen 22 is in communication with the tubular inflation leg 16 which, in turn, is connected to an inflation/deflation device 26 which may be any of a variety of such devices as are commercially available. The distal end of the inflation lumen 22 opens into the interior of the balloon 14, as indicated diagrammatically at a port 28 in FIG. 3. Thus, the balloon 14 may be inflated and deflated through the lumen 22 by operation of the inflation/deflation device 26. As will be described in further detail, the balloon is formed to include a multiplicity of minute pores 30 which may be substantially regularly spaced about the surface of the balloon 14. The pores 30 serve to deliver the medication to the wall of the organ being treated. The other, larger lumen 24, is connected to the tubular guidewire leg 18 and serves to receive a guidewire 32. The guidewire lumen extends fully the length of the catheter shaft, and terminates at a distal exit orifice 34. The guidewire 32 thus can be projected distally beyond the distal end of the catheter shaft and may be manipulated to facilitate placement of the catheter in the body lumen as will be appreciated by those familiar with the art. For example, the guidewire may be of the steerable type as described in further detail in U.S. Pat. No. 4,545,390 (Leary).
    [0026] In order to develop the electrical field necessary for iontophoresis or iontohydrokinesis, the catheter includes a conductor that extends from the proximal end of the catheter to and into the balloon [0026] 14. In the illustrative embodiment, the conductor is in the form of an insulated wire 36 that may merge into the inflation/deflation lumen 22 at the proximal end of the catheter and may extend distally through the lumen 22 and into the balloon. The distal portion of the conductor 36 disposed within the balloon 14 may be uninsulated to define the inner, driving electrode. Preferably, the driving electrode is wrapped helically about the portion of the shaft 12A that extends through the balloon 14. The helical configuration of the electrode enhances uniform radial distribution of the electrical field. In alternative embodiments, the conductive wire may be conducted to one or more metallic band electrodes extending about the shaft within the balloon, for example, as to a mid-balloon marker band 38. Alternately, the electrode may be in the form of a wire mesh within the balloon about the catheter shaft.
    [0027] In the three leg embodiment of the catheter, the catheter includes three lumens as indicated in FIG. 2A. In this embodiment, the catheter shaft [0027] 12A is formed to include an inflation lumen 22A, a guidewire lumen 24A and a return lumen 40. The proximal end of the return lumen 40 is connected to the tubular return leg 20 at the proximal end of the catheter. The distal end of the return lumen 40 opens into the interior of the balloon at a port 42 illustrated in FIG. 3A. As will be described further below, the three leg embodiment enables a continuous flow of liquid into and out of the balloon 14.
    [0028] The size of the balloon [0028] 14 is selected so that when inflated it will be slightly larger than the body lumen into which the catheter is to be inserted. This is desirable in order that the balloon may be pressed lightly against the inner luminal surface of the targeted organ so that medication that is emitted from the balloon will be applied directly and intimately against the inner luminal surface of the organ. The minute pores 30 may be of the order of 400 angstroms to 25 microns in diameter. The balloon 14 preferably is made of an inelastic polymeric material of the type used in balloon angioplasty catheters as will be familiar to those skilled in the art. For example, the balloon may be formed from polyethylene terephthalate. The inelasticity of the balloon material serves to prevent the pores 30 from becoming too large during inflation of the balloon, thus undesirably varying the flow rate of the medication.
    [0029] The external return electrodes [0029] 13 and the internal driving electrode are connected to a direct current source 44. In order to reduce the risk of disrupting the patient's heart rhythm when the electrodes are in the region of the heart, the current to the electrodes preferably is pulsed on during the systole phase of the cardiac pumping action and off during diastolic phase.
    [0030] In use, the external electrodes [0030] 20 are positioned circumferentially about the patient. The catheter 10 is inserted into the patient and manipulated into the desired location of the desired body lumen. The catheter 10 may be positioned by any one of numerous well-known methods such as the use of guidewire 32. Once the catheter 10 has been advanced so that the balloon 14 is at the desired location, the balloon 14 is inflated to fill the body lumen and seal the balloon against the inner surface of the body lumen under light pressure. Preferably, the balloon is pressurized not substantially more than approximately 150 mmHg. Power to the electrodes is provided to develop an electric field radiating outward from the inner driving electrode to the outer return electrodes 20. Due to the charged nature of the medication or the water with which the medication may be mixed, the medication flows radially outward along the lines of the electric field, thus permeating the targeted tissue located radially outward from the balloon 14. The medication thus is localized to the target organ.
    [0031] The external electrodes are positioned, as shown in FIG. 4, about the patient's exterior so that the medication will flow radially outward in all directions. The charge applied to each of the electrodes may be varied when the internal electrode is not located centrally inside the patient so that the field is of equal strength through 360°. The current strength, duration of current application and location of the external electrodes may be varied to further focus the flow of medication. Patch electrodes, which are known in the art, may be used as the external electrodes. Thus, the direction and uniformity of dispersion and permeation of the medication may be controlled. The polarity of the inner driving and external return electrode is selected with reference to the sense of the ionic compound to assure dispersion in a radially outward direction. [0031]
    [0032] The method and apparatus of the present invention provide numerous advantages. By utilizing the electrode configuration of the present invention, specific internal locations of a patient may be targeted for treatment with a particular medication. Furthermore, the permeation of the medication into the body tissue external the balloon is induced by creating an electric field and not by increasing pressure on the liquid in the balloon [0032] 14. Consequently, mechanical stress to the body lumen is kept at a minimum. By introducing the medication to the balloon and only allowing it to pass radially outward through the balloon pores, an excessive concentration of medication is not introduced to the patient.
    [0033] While the foregoing method and apparatus are applicable to a wide variety of body organs and lumens, they have particular use in blood vessels such as arteries. The catheter [0033] 10 shown in FIG. 1 may be used in the primary treatment of a lesion (stenosis) with an appropriate medication to reduce the size of the lesion or to prevent restenosis after an angioplasty. In primary treatment of a lesion, the catheter 10 is inserted into an artery until the balloon 14 is positioned against the region of the dilated stenosis. A suitable liquid medication (ionic or coupled to a polar carrier molecule) is infused into the balloon 14 to inflate the balloon and seal it against the luminal surface. An electric field then is induced between the internal driving electrode and the external return electrodes 13 so that the medication flows radially outward through the pores 30 of the balloon 14 and into the arterial wall to break down the stenotic material and cause reduction in the size of the stenosis.
    [0034] When used for treating an artery after a conventional angioplasty to prevent restenosis, an antirestenosis drug, such as heparin, is used to inflate the balloon [0034] 14. Once the electric field has been induced, the heparin or other appropriate medication will flow outwardly and permeate the arterial wall. The degree to which the medication permeates the wall can be controlled by varying the strength of the electric field and the length of time that the electric field is maintained. In the illustrated catheter, the inflation of the balloon 14 shuts off blood flow through the artery during the procedure. The present method may be employed in an autoperfusion catheter of the type described in U.S. Pat. No. 4,581,017 (Sahota) to allow blood flow through the catheter to distally perfuse the artery while the balloon is inflated. As described in that patent, the disclosure of which is hereby incorporated by reference in its entirety, an opening is provided in the catheter shaft wall proximally of the balloon to allow blood to perfuse through the catheter distally of the balloon.
    [0035] It sometimes may occur that the ionic charge of the molecule may change during the procedure, for example, if the pH of the fluid changes. Such pH change may result from interaction of the liquid with the electrode as may be a function of the duration of the procedure. In order to avoid adverse changes in pH, the liquid may be aspirated periodically from the catheter and replaced with fresh liquid. This procedure may be used with the two lumen configuration described above and illustrated in FIGS. 1 and 2. Alternately with the three lumen embodiment, represented by FIG. 2A, a continuous flow of liquid may be established through the balloon, flow of liquid being toward and into the balloon through the inflation lumen [0035] 22A and out of and away from the balloon through the return lumen 40. The return leg 20 at the proximal end of the catheter 10 preferably is provided with a variable flow resistor 46 by which the back pressure of the returning outflowing liquid may be controlled. By operating the inflation device and variable restrictor 46, the pressure developed within the balloon and rate of continuous flow through the system may be controlled as desired.
    [0036] Thus, I have described the invention by which medication may be applied selectively to a targeted internal organ or body lumen, such as an artery. It should be understood, while the invention has been described with regard to treatment of tissue adjacent a body lumen, the invention may be practiced in any location where it is desired to apply medication to a vessel or organ having a lumen accessible by a catheter. For example, the apparatus may be utilized to treat the heart or coronary arteries. The catheter may be passed into a lumen in a particular organ or may even be inserted into a lumen formed in an organ or tumor for the express purpose of receiving the catheter. [0036]
    [0037] It should be understood that the foregoing description of the invention is intended merely to be illustrative thereof and that other embodiments, modifications and equivalents may be apparent to those skilled in the art without departing from its spirit. [0037]
    权利要求:
    Claims (23)
    [1" id="US-20010001816-A1-CLM-00001] 1. An apparatus for selectively inducing the permeation of liquid to a targeted portion of internal tissue in the body of a patient comprising:
    at least one external electrode positioned outside of the patient's body;
    a catheter having an elongate shaft, the catheter having proximal and distal ends, means extending along the shaft for delivering said liquid from the proximal to the distal region of the catheter and for emitting said liquid from the catheter;
    an internal electrode carried by the catheter at the distal end of the catheter;
    conductor means extending through the catheter shaft and being electrically connected to the internal electrode, the proximal end of the conductor being connectible to a source of electrical energy; and
    means for inducing an electric field between said internal electrode and said at least one external electrode so that fluid emitted from the distal end of the catheter will flow in a direction extending from the internally placed electrode outwardly toward the external electrode.
    [2" id="US-20010001816-A1-CLM-00002] 2. An apparatus as defined in
    claim 1 , wherein the external electrode means is adapted to extend circumferentially about a portion of the patient's body.
    [3" id="US-20010001816-A1-CLM-00003] 3. An apparatus as defined in
    claim 1 wherein the means for emitting said fluid comprises a flexible, inflatable balloon mounted to the distal end of the catheter shaft, the balloon having a plurality of pores formed therethrough to enable the liquid to flow out of the pores.
    [4" id="US-20010001816-A1-CLM-00004] 4. An apparatus as defined in
    claim 3 wherein the balloon is formed from a substantially inelastic material.
    [5" id="US-20010001816-A1-CLM-00005] 5. An apparatus as defined in any of claims 1-4 wherein the catheter further comprises a lumen extending through the catheter shaft and terminating in an outlet distally beyond the balloon and means for directing blood flow through the lumen and out of the distal outlet to permit distal perfusion of blood during inflation of the balloon.
    [6" id="US-20010001816-A1-CLM-00006] 6. A catheter for selectively inducing the permeation of liquid to a targeted portion of internal tissue in the body of a patient comprising:
    an elongate shaft having proximal and distal ends;
    means extending along the shaft for delivering said liquid from the proximal end of the catheter to the distal region of the catheter;
    means for emitting the liquid from the catheter;
    an internal electrode carried by the catheter at the distal end of the catheter;
    conductor means extending through the catheter shaft and being electrically connected to the internal electrode, the proximal end of the conductor being connectible to a source of electrical energy.
    [7" id="US-20010001816-A1-CLM-00007] 7. A catheter as defined in
    claim 6 wherein the means for emitting the liquid from the catheter comprises a flexible, inflatable balloon mounted to the distal end of the catheter shaft, the balloon having a plurality of pores formed therethrough to enable the liquid to flow out of the pores.
    [8" id="US-20010001816-A1-CLM-00008] 8. A catheter as defined in
    claim 3 wherein the balloon is formed from a substantially inelastic material.
    [9" id="US-20010001816-A1-CLM-00009] 9. An apparatus as defined in any of claims 6-8 wherein the catheter further comprises a lumen extending through the catheter shaft and terminating in an outlet distally beyond the balloon, the lumen being adapted to receive blood proximally of the balloon and to enable blood to flow through the catheter and be emitted distally of the balloon to permit distal perfusion during inflation of the balloon.
    [10" id="US-20010001816-A1-CLM-00010] 10. A method for selectively inducing the permeation of liquid to a targeted portion of internal tissue in the body of a patient comprising the steps of:
    generating a polar electric field in which one pole of the field is disposed internally of the targeted portion of the tissue and the return pole is external of the targeted portion of the tissue;
    supplying liquid having polar molecules to a location in the body adjacent the targeted portion of the tissue;
    said electric field being polarized with respect to the polarization of the polar molecules such that the electric field will induce flow of the polar molecules through the targeted portion of the internal tissue toward the other pole of the field.
    [11" id="US-20010001816-A1-CLM-00011] 11. A method as defined in
    claim 10 wherein said step of generating the polarized electric field comprises:
    providing an external electrode and locating the external electrode outside of the patient's body;
    providing an internally placeable electrode and inserting the internally placeable electrode into the patient and within the targeted portion of the internal tissue whereby the electric field will cause the liquid to permeate the targeted portion of the internal tissue as it advances from the internal electrode toward the external electrode.
    [12" id="US-20010001816-A1-CLM-00012] 12. A method as defined in claims 10 or 11 wherein said targeted portion of internal tissue comprises a body organ having a natural lumen extending therethrough and where the internal electrode is inserted into the lumen.
    [13" id="US-20010001816-A1-CLM-00013] 13. A method as defined in
    claim 12 wherein the step of supplying fluid comprises supplying the liquid to the lumen of the organ.
    [14" id="US-20010001816-A1-CLM-00014] 14. A method as recited in any of claims 10 or 11 further comprising the step of pulsing the electric field in phase with the patient's cardiac rhythm.
    [15" id="US-20010001816-A1-CLM-00015] 15. A method as recited in
    claim 12 further comprising the step of pulsing the electric field in phase with a patient's cardiac rhythm.
    [16" id="US-20010001816-A1-CLM-00016] 16. A method as defined in
    claim 13 further comprising the step of pulsing the electric field in phase with the patient's cardiac rhythm.
    [17" id="US-20010001816-A1-CLM-00017] 17. A method as defined in claims 10, 11 or 13 wherein the electrode is inserted into an artery in the region of a stenosis and where the liquid includes a compound adapted to treat the region of the stenosis.
    [18" id="US-20010001816-A1-CLM-00018] 18. A method as defined in
    claim 12 wherein the electrode is inserted into an artery in the region of a stenosis and where the liquid includes a compound adapted to treat the region of the stenosis.
    [19" id="US-20010001816-A1-CLM-00019] 19. A method as recited in claims 10, 11 or 13 wherein the internal electrode is inserted into an artery adjacent the site of a stenosis treated by angioplasty and said liquid contains medication adapted to retard restenosis.
    [20" id="US-20010001816-A1-CLM-00020] 20. A method as recited in
    claim 12 wherein the internal electrode is inserted into an artery adjacent the site of a stenosis treated by angioplasty and said liquid contains medication adapted to retard restenosis.
    [21" id="US-20010001816-A1-CLM-00021] 21. A method as defined in claims 10, 12 or 13 wherein the step of supplying said liquid comprises:
    providing a catheter as defined in
    claim 6 and inserting the catheter into the patient.
    [22" id="US-20010001816-A1-CLM-00022] 22. A method as defined in
    claim 21 wherein the step of inserting the catheter comprises inserting the catheter percutaneously.
    [23" id="US-20010001816-A1-CLM-00023] 23. A method for inducing the permeation of a fluid having charged molecules into internal tissue comprising the steps of:
    providing electrodes external of a patient's body;
    inserting a balloon catheter having an elongate flexible shaft, with a porous balloon at the distal end of said shaft, and an internal electrode being positioned inside said balloon on said elongate flexible shaft,
    inflating said balloon with said fluid; and
    developing an electric field flowing from said internal electrode to said external electrodes so that said liquid flows radially outward through said pores in said balloon to said tissue to be treated.
    类似技术:
    公开号 | 公开日 | 专利标题
    US5669874A|1997-09-23|Method and apparatus for inducing the permeation of medication into internal tissue
    US8666496B2|2014-03-04|Methods and apparatus for electrical treatment using balloon and electrode
    US5807306A|1998-09-15|Polymer matrix drug delivery apparatus
    US5800392A|1998-09-01|Microporous catheter
    CN107106820B|2021-03-19|Chemical ablation and methods for treating various diseases
    US5499971A|1996-03-19|Method for iontophoretically delivering drug adjacent to a heart
    US5112305A|1992-05-12|Catheter device for intramural delivery of therapeutic agents
    EP0533816B1|1995-06-14|Drug delivery apparatus
    US6648881B2|2003-11-18|Method for reducing arterial restenosis in the presence of an intravascular stent
    US5364356A|1994-11-15|Sleeve catheter
    US5728068A|1998-03-17|Multi-purpose balloon catheter
    US5505700A|1996-04-09|Electro-osmotic infusion catheter
    EP0814719B1|2003-10-08|Ultrasound therapy device
    JPH09510895A|1997-11-04|How to treat deep sick parts of the body with drugs
    JP2000508220A|2000-07-04|Electroporation and iontophoresis catheter with porous balloon
    EP2265204B1|2017-12-06|Device comprising an enclosure and an interior electrode for delivering energy to a mammal
    WO1994005369A1|1994-03-17|Internal iontophoresis electrical circuit and waveforms
    US20180104456A1|2018-04-19|Venous anatomy drug delivery balloon
    JP3462561B2|2003-11-05|Drug administration device
    同族专利:
    公开号 | 公开日
    EP0527920B1|2000-10-04|
    AU642020B2|1993-10-07|
    EP0527920A4|1993-07-28|
    US5236413B1|1996-06-18|
    AT207375T|2001-11-15|
    CA2081666A1|1991-11-08|
    DE69132787D1|2001-11-29|
    US5425703A|1995-06-20|
    JPH05508782A|1993-12-09|
    DE69132787T2|2002-08-01|
    DE69132438T2|2001-05-10|
    US5236413A|1993-08-17|
    AU7901091A|1991-11-27|
    JP3372250B2|2003-01-27|
    EP1002554B1|2001-10-24|
    WO1991016945A1|1991-11-14|
    US5810763A|1998-09-22|
    EP1002554A1|2000-05-24|
    US6389314B2|2002-05-14|
    DE69132438D1|2000-11-09|
    US5549603A|1996-08-27|
    EP0527920A1|1993-02-24|
    CA2081666C|1998-12-29|
    US5669874A|1997-09-23|
    US6195583B1|2001-02-27|
    AT196740T|2000-10-15|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US20040087902A1|2002-10-30|2004-05-06|Jacob Richter|Drug eluting medical device with an expandable portion for drug release|
    WO2009108659A1|2008-02-25|2009-09-03|The University Of North Carolina At Chapel Hill|Delivery apparatus and associated method|
    WO2016008725A1|2014-07-18|2016-01-21|Combat Medical Sl|Catheter for the delivery of therapeutic fluid|
    US10695562B2|2009-02-26|2020-06-30|The University Of North Carolina At Chapel Hill|Interventional drug delivery system and associated methods|US600290A||1898-03-08||Therapeutic electrode |
    US578611A||1897-03-09||Thirds to louis f |
    US791730A|1903-06-01|1905-06-06|Johan Jakob Stanger|Electrical mouth-bath.|
    US866180A|1907-06-13|1907-09-17|Cutler Taylor Ball|Combined applicator and dilator.|
    US873021A|1907-08-02|1907-12-10|Harlow R Cool|Electrotherapeutic syringe.|
    US2123920A|1934-06-01|1938-07-19|Servel Inc|Refrigeration|
    US2123980A|1934-07-21|1938-07-19|G M Basford Company|Therapeutic treatment|
    US3411507A|1964-04-01|1968-11-19|Medtronic Inc|Method of gastrointestinal stimulation with electrical pulses|
    US3618601A|1969-10-16|1971-11-09|Thatcher W Richardson|Iontophoresis unit|
    US3716054A|1970-08-11|1973-02-13|W Porter|Apparatus for applying medication to teeth and body tissue|
    US3991755A|1973-07-27|1976-11-16|Medicon, Inc.|Iontophoresis apparatus for applying local anesthetics|
    US4309989A|1976-02-09|1982-01-12|The Curators Of The University Of Missouri|Topical application of medication by ultrasound with coupling agent|
    SU843999A1|1977-10-11|1981-07-07|Харьковская Областная Клиническаябольница|Probe for intracavitary electrophoresis|
    US4250878A|1978-11-22|1981-02-17|Motion Control, Inc.|Non-invasive chemical species delivery apparatus and method|
    US4383529A|1980-11-03|1983-05-17|Wescor, Inc.|Iontophoretic electrode device, method and gel insert|
    US4405311A|1980-12-08|1983-09-20|Greatbatch Enterprises, Inc.|Method and apparatus for direct electrical injection of gold ions into tissue such as bone|
    US4411648A|1981-06-11|1983-10-25|Board Of Regents, The University Of Texas System|Iontophoretic catheter device|
    US4417576A|1982-02-25|1983-11-29|Baran Ostap E|Double-wall surgical cuff|
    US4423725A|1982-03-31|1984-01-03|Baran Ostap E|Multiple surgical cuff|
    US4636195A|1982-04-02|1987-01-13|Harvey Wolinsky|Method and apparatus for removing arterial constriction|
    SU1069827A1|1982-09-17|1984-01-30|Запорожский медицинский институт|Endotracheal tube|
    SU1069826A1|1982-09-17|1984-01-30|Запорожский медицинский институт|Endotracheal tube|
    US4545390A|1982-09-22|1985-10-08|C. R. Bard, Inc.|Steerable guide wire for balloon dilatation procedure|
    US4522194A|1983-02-18|1985-06-11|Baylor College Of Medicine|Method and an apparatus for intra-aortic balloon monitoring and leak detection|
    US4581017B1|1983-03-07|1994-05-17|Bard Inc C R|Catheter systems|
    FR2542886B1|1983-03-15|1985-08-16|Tecnimatic|METHOD AND DEVICE FOR TIGHTENING SCREWS OR THE LIKE TO THE LIMIT OF ELASTIC DEFORMATION|
    US4506680A|1983-03-17|1985-03-26|Medtronic, Inc.|Drug dispensing body implantable lead|
    JPS626754B2|1983-09-02|1987-02-13|Nisshin Steel Co Ltd||
    US4569673A|1984-01-12|1986-02-11|Battelle Development Corporation|Bacterial barrier for indwelling catheters and other medical devices|
    US4574807A|1984-03-02|1986-03-11|Carl Hewson|Method and apparatus for pacing the heart employing external and internal electrodes|
    US5135477A|1984-10-29|1992-08-04|Medtronic, Inc.|Iontophoretic drug delivery|
    US4577642A|1985-02-27|1986-03-25|Medtronic, Inc.|Drug dispensing body implantable lead employing molecular sieves and methods of fabrication|
    AT385894B|1985-10-04|1988-05-25|Basem Dr Nashef|TUBULAR PROBE|
    US4752285B1|1986-03-19|1995-08-22|Univ Utah Res Found|Methods and apparatus for iontophoresis application of medicaments|
    US4915685A|1986-03-19|1990-04-10|Petelenz Tomasz J|Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange|
    EP0249964A3|1986-06-17|1988-07-20|Mitsubishi Rayon Co., Ltd.|Polycarbonate resin composition|
    US4767402A|1986-07-08|1988-08-30|Massachusetts Institute Of Technology|Ultrasound enhancement of transdermal drug delivery|
    US5042975A|1986-07-25|1991-08-27|Rutgers, The State University Of New Jersey|Iontotherapeutic device and process and iontotherapeutic unit dose|
    IN171162B|1987-05-20|1992-08-08|Rieter Ag Switzerland Maschf||
    US4892519A|1987-12-03|1990-01-09|Advanced Cardiovascular Systems, Inc.|Steerable perfusion dilatation catheter|
    DE68925030T2|1988-01-21|1996-07-25|Massachusetts Inst Technology|MOLECULE TRANSPORT THROUGH FABRICS WITH THE USE OF ELECTROPORATION.|
    US4944745A|1988-02-29|1990-07-31|Scimed Life Systems, Inc.|Perfusion balloon catheter|
    DE3809815C2|1988-03-23|1990-06-28|Peter 7910 Neu-Ulm De Zimmer||
    US4877031A|1988-07-22|1989-10-31|Advanced Cardiovascular Systems, Inc.|Steerable perfusion dilatation catheter|
    DE3915636C1|1989-05-12|1990-04-26|Sass, Wolfgang, Dr.||
    US4994033A|1989-05-25|1991-02-19|Schneider Inc.|Intravascular drug delivery dilatation catheter|
    AT138815T|1990-01-15|1996-06-15|Cino Rossi|IONTOPHORESE DEVICE|
    US5236413B1|1990-05-07|1996-06-18|Andrew J Feiring|Method and apparatus for inducing the permeation of medication into internal tissue|
    EP0533816B1|1990-06-15|1995-06-14|Cortrak Medical, Inc.|Drug delivery apparatus|
    US5498238A|1990-06-15|1996-03-12|Cortrak Medical, Inc.|Simultaneous angioplasty and phoretic drug delivery|
    US5250022A|1990-09-25|1993-10-05|Rutgers, The State University Of New Jersey|Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose|
    US5232411A|1991-07-26|1993-08-03|Nissan Motor Co., Ltd.|Structure for automatic transmission|
    US5232441A|1992-05-18|1993-08-03|Physion S.R.L.|Method of treating schistosomal infestations by iontophoresis|
    US5304120A|1992-07-01|1994-04-19|Btx Inc.|Electroporation method and apparatus for insertion of drugs and genes into endothelial cells|
    US5256141A|1992-12-22|1993-10-26|Nelson Gencheff|Biological material deployment method and apparatus|US5236413B1|1990-05-07|1996-06-18|Andrew J Feiring|Method and apparatus for inducing the permeation of medication into internal tissue|
    US5458568A|1991-05-24|1995-10-17|Cortrak Medical, Inc.|Porous balloon for selective dilatation and drug delivery|
    US5499971A|1990-06-15|1996-03-19|Cortrak Medical, Inc.|Method for iontophoretically delivering drug adjacent to a heart|
    EP0533816B1|1990-06-15|1995-06-14|Cortrak Medical, Inc.|Drug delivery apparatus|
    US5498238A|1990-06-15|1996-03-12|Cortrak Medical, Inc.|Simultaneous angioplasty and phoretic drug delivery|
    US5599296A|1991-02-14|1997-02-04|Wayne State University|Apparatus and method of delivery of gas-supersaturated liquids|
    US5769812A|1991-07-16|1998-06-23|Heartport, Inc.|System for cardiac procedures|
    US5558644A|1991-07-16|1996-09-24|Heartport, Inc.|Retrograde delivery catheter and method for inducing cardioplegic arrest|
    US6482171B1|1991-07-16|2002-11-19|Heartport, Inc.|Multi-lumen catheter|
    US5584803A|1991-07-16|1996-12-17|Heartport, Inc.|System for cardiac procedures|
    US5263925A|1991-07-22|1993-11-23|Gilmore Jr Thomas F|Photopheresis blood treatment|
    CA2074304C|1991-08-02|1996-11-26|Cyril J. Schweich, Jr.|Drug delivery catheter|
    US6224619B1|1991-12-17|2001-05-01|Heartport, Inc.|Blood vessel occlusion trocar having size and shape varying insertion body|
    US5344398A|1992-02-25|1994-09-06|Japan Crescent, Inc.|Heated balloon catheter|
    US5578008A|1992-04-22|1996-11-26|Japan Crescent, Inc.|Heated balloon catheter|
    US6132419A|1992-05-22|2000-10-17|Genetronics, Inc.|Electroporetic gene and drug therapy|
    US5501662A|1992-05-22|1996-03-26|Genetronics, Inc.|Implantable electroporation method and apparatus for drug and gene delivery|
    US5507724A|1992-07-01|1996-04-16|Genetronics, Inc.|Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells|
    US5304120A|1992-07-01|1994-04-19|Btx Inc.|Electroporation method and apparatus for insertion of drugs and genes into endothelial cells|
    AU4792993A|1992-07-30|1994-03-03|Andrew Stone|Dialysis system, method and filtrate solution composition|
    US5755968A|1992-07-30|1998-05-26|Stone; Andrew|Dialysis system and method for removing toxic matter from the serum of the large intestine|
    US5462520A|1992-08-17|1995-10-31|Genetronics, Inc.|Transsurface drug delivery by electrofusion of microbubbles to the tissue surface|
    US5688233A|1992-08-17|1997-11-18|Genetronics, Inc.|Electronincorporation enhanced transdermal delivery of molecules|
    US5807306A|1992-11-09|1998-09-15|Cortrak Medical, Inc.|Polymer matrix drug delivery apparatus|
    US5256141A|1992-12-22|1993-10-26|Nelson Gencheff|Biological material deployment method and apparatus|
    US5401239A|1993-03-11|1995-03-28|Physion S.R.L.|Electromotive treatment of catheter-rerelated infections|
    WO1994021320A1|1993-03-15|1994-09-29|Advanced Cardiovascular Systems, Inc.|Fluid delivery catheter|
    US5861168A|1993-06-11|1999-01-19|The Board Of Trustees Of The Leland Stanford Junior University|Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury|
    US5852058A|1993-06-11|1998-12-22|The Board Of Trustees Of The Leland Stanford Junior University|Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury|
    US5891459A|1993-06-11|1999-04-06|The Board Of Trustees Of The Leland Stanford Junior University|Enhancement of vascular function by modulation of endogenous nitric oxide production or activity|
    DE69637676D1|1995-11-09|2008-10-23|Univ R|Use of locally administered lysines to IMPROVE VASCULAR FUNCTION|
    US5344402A|1993-06-30|1994-09-06|Cardiovascular Dynamics, Inc.|Low profile perfusion catheter|
    ES2241032T3|1996-01-08|2005-10-16|Impulse Dynamics Nv|CARDIAC ACTIVITY CONTROL DEVICE THAT USES THE NON-EXCITING PRE-STIMULATION SINCORNIZED.|
    US9713723B2|1996-01-11|2017-07-25|Impulse Dynamics Nv|Signal delivery through the right ventricular septum|
    US8825152B2|1996-01-08|2014-09-02|Impulse Dynamics, N.V.|Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue|
    US8321013B2|1996-01-08|2012-11-27|Impulse Dynamics, N.V.|Electrical muscle controller and pacing with hemodynamic enhancement|
    US5634899A|1993-08-20|1997-06-03|Cortrak Medical, Inc.|Simultaneous cardiac pacing and local drug delivery method|
    US5421818A|1993-10-18|1995-06-06|Inner Ear Medical Delivery Systems, Inc.|Multi-functional inner ear treatment and diagnostic system|
    US5397307A|1993-12-07|1995-03-14|SchneiderInc.|Drug delivery PTCA catheter and method for drug delivery|
    US5419763B1|1994-01-04|1997-07-15|Cor Trak Medical Inc|Prostatic drug-delivery catheter|
    JP3403233B2|1994-01-20|2003-05-06|テルモ株式会社|Balloon catheter|
    US5415636A|1994-04-13|1995-05-16|SchneiderInc|Dilation-drug delivery catheter|
    US5486160A|1994-05-04|1996-01-23|Physion S.R.L.|Device and method for the combined electropharmacological treatment of the bladder and the prostatic urethra|
    US5478309A|1994-05-27|1995-12-26|William P. Sweezer, Jr.|Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery|
    US5505700A|1994-06-14|1996-04-09|Cordis Corporation|Electro-osmotic infusion catheter|
    US5728068A|1994-06-14|1998-03-17|Cordis Corporation|Multi-purpose balloon catheter|
    US5681278A|1994-06-23|1997-10-28|Cormedics Corp.|Coronary vasculature treatment method|
    US5900433A|1995-06-23|1999-05-04|Cormedics Corp.|Vascular treatment method and apparatus|
    US6024743A|1994-06-24|2000-02-15|Edwards; Stuart D.|Method and apparatus for selective treatment of the uterus|
    US6009877A|1994-06-24|2000-01-04|Edwards; Stuart D.|Method for treating a sphincter|
    US5505730A|1994-06-24|1996-04-09|Stuart D. Edwards|Thin layer ablation apparatus|
    US7165551B2|1998-02-19|2007-01-23|Curon Medical, Inc.|Apparatus to detect and treat aberrant myoelectric activity|
    US8906010B2|1998-02-19|2014-12-09|Mederi Therapeutics, Inc.|Graphical user interface for association with an electrode structure deployed in contact with a tissue region|
    US6423058B1|1998-02-19|2002-07-23|Curon Medical, Inc.|Assemblies to visualize and treat sphincters and adjoining tissue regions|
    US5681308A|1994-06-24|1997-10-28|Stuart D. Edwards|Ablation apparatus for cardiac chambers|
    US6440128B1|1998-01-14|2002-08-27|Curon Medical, Inc.|Actively cooled electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions|
    US6056744A|1994-06-24|2000-05-02|Conway Stuart Medical, Inc.|Sphincter treatment apparatus|
    US6273886B1|1998-02-19|2001-08-14|Curon Medical, Inc.|Integrated tissue heating and cooling apparatus|
    US6258087B1|1998-02-19|2001-07-10|Curon Medical, Inc.|Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions|
    US6402744B2|1998-02-19|2002-06-11|Curon Medical, Inc.|Systems and methods for forming composite lesions to treat dysfunction in sphincters and adjoining tissue regions|
    US20030135206A1|1998-02-27|2003-07-17|Curon Medical, Inc.|Method for treating a sphincter|
    US6358245B1|1998-02-19|2002-03-19|Curon Medical, Inc.|Graphical user interface for association with an electrode structure deployed in contact with a tissue region|
    US6464697B1|1998-02-19|2002-10-15|Curon Medical, Inc.|Stomach and adjoining tissue regions in the esophagus|
    US6405732B1|1994-06-24|2002-06-18|Curon Medical, Inc.|Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors|
    US6325798B1|1998-02-19|2001-12-04|Curon Medical, Inc.|Vacuum-assisted systems and methods for treating sphincters and adjoining tissue regions|
    US5575788A|1994-06-24|1996-11-19|Stuart D. Edwards|Thin layer ablation apparatus|
    US6355031B1|1998-02-19|2002-03-12|Curon Medical, Inc.|Control systems for multiple electrode arrays to create lesions in tissue regions at or near a sphincter|
    AU752243B2|1998-02-19|2002-09-12|Curon Medical, Inc.|Electrosurgical sphincter treatment apparatus|
    US5514092A|1994-08-08|1996-05-07|SchneiderInc.|Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration|
    AUPM982694A0|1994-12-02|1995-01-05|University Of Queensland, The|Iontophoresis method and apparatus|
    US5569198A|1995-01-23|1996-10-29|Cortrak Medical Inc.|Microporous catheter|
    US5749845A|1995-01-25|1998-05-12|Iotek, Inc.|Delivering an agent to an organ|
    US5735817A|1995-05-19|1998-04-07|Shantha; T. R.|Apparatus for transsphenoidal stimulation of the pituitary gland and adjoining brain structures|
    US5865801A|1995-07-18|1999-02-02|Houser; Russell A.|Multiple compartmented balloon catheter with external pressure sensing|
    US6302875B1|1996-10-11|2001-10-16|Transvascular, Inc.|Catheters and related devices for forming passageways between blood vessels or other anatomical structures|
    US6913763B2|1996-11-19|2005-07-05|Intrabrain International Nv|Method and device for enhanced delivery of a biologically active agent through the spinal spaces into the central nervous system of a mammal|
    WO1997018855A1|1995-11-21|1997-05-29|Eduard Naumovich Lerner|Device for enhanced delivery of biologically active substances and compounds in an organism|
    US6678553B2|1995-11-21|2004-01-13|Intraabrain International Nv|Device for enhanced delivery of biologically active substances and compounds in an organism|
    US5779661A|1995-12-11|1998-07-14|Physion, S.R.L.|Method of treating dysfunctional bladder syndromes by electromotive drug administration|
    EP0780139A1|1995-12-22|1997-06-25|PHYSION S.r.l.|Device for the combined electropharmacological treatment of the bladder and the prostatic urethra|
    US9289618B1|1996-01-08|2016-03-22|Impulse Dynamics Nv|Electrical muscle controller|
    US7167748B2|1996-01-08|2007-01-23|Impulse Dynamics Nv|Electrical muscle controller|
    US6032077A|1996-03-06|2000-02-29|Cardiac Pathways Corporation|Ablation catheter with electrical coupling via foam drenched with a conductive fluid|
    US5800482A|1996-03-06|1998-09-01|Cardiac Pathways Corporation|Apparatus and method for linear lesion ablation|
    US6015407A|1996-03-06|2000-01-18|Cardiac Pathways Corporation|Combination linear ablation and cooled tip RF catheters|
    US5895417A|1996-03-06|1999-04-20|Cardiac Pathways Corporation|Deflectable loop design for a linear lesion ablation apparatus|
    US5797903A|1996-04-12|1998-08-25|Ep Technologies, Inc.|Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces|
    EP0959933A1|1996-05-03|1999-12-01|Emed Corporation|Combined coronary stent deployment and local delivery of an agent|
    US8353908B2|1996-09-20|2013-01-15|Novasys Medical, Inc.|Treatment of tissue in sphincters, sinuses, and orifices|
    US20040219660A1|2001-12-14|2004-11-04|Dev Sukhendu B.|Electroporation-mediated intravascular delivery|
    US5944710A|1996-06-24|1999-08-31|Genetronics, Inc.|Electroporation-mediated intravascular delivery|
    US5797868A|1996-07-25|1998-08-25|Cordis Corporation|Photodynamic therapy balloon catheter|
    US5709653A|1996-07-25|1998-01-20|Cordis Corporation|Photodynamic therapy balloon catheter with microporous membrane|
    US5720775A|1996-07-31|1998-02-24|Cordis Corporation|Percutaneous atrial line ablation catheter|
    US7908003B1|1996-08-19|2011-03-15|Mr3 Medical Llc|System and method for treating ischemia by improving cardiac efficiency|
    US7840264B1|1996-08-19|2010-11-23|Mr3 Medical, Llc|System and method for breaking reentry circuits by cooling cardiac tissue|
    US6066489A|1996-08-30|2000-05-23|Arrow International, Inc.|Method for treating blood borne viral pathogens such as immunodeficiency virus|
    EP0835673A3|1996-10-10|1998-09-23|SchneiderInc.|Catheter for tissue dilatation and drug delivery|
    US5704908A|1996-10-10|1998-01-06|Genetronics, Inc.|Electroporation and iontophoresis catheter with porous balloon|
    US5722403A|1996-10-28|1998-03-03|Ep Technologies, Inc.|Systems and methods using a porous electrode for ablating and visualizing interior tissue regions|
    US6059726A|1996-11-08|2000-05-09|The Regents Of The University Of California|Method for locating the atrio-ventricularjunction of the heart and injecting active substances therein|
    US6076012A|1996-12-19|2000-06-13|Ep Technologies, Inc.|Structures for supporting porous electrode elements|
    US6001094A|1997-01-09|1999-12-14|Vidacare International, Inc.|Implantable soluble electrode system|
    US7048717B1|1999-09-27|2006-05-23|Essex Technology, Inc.|Rotate-to-advance catheterization system|
    US5755687A|1997-04-01|1998-05-26|Heartport, Inc.|Methods and devices for occluding a patient's ascending aorta|
    US7027869B2|1998-01-07|2006-04-11|Asthmatx, Inc.|Method for treating an asthma attack|
    US7992572B2|1998-06-10|2011-08-09|Asthmatx, Inc.|Methods of evaluating individuals having reversible obstructive pulmonary disease|
    US7921855B2|1998-01-07|2011-04-12|Asthmatx, Inc.|Method for treating an asthma attack|
    US6634363B1|1997-04-07|2003-10-21|Broncus Technologies, Inc.|Methods of treating lungs having reversible obstructive pulmonary disease|
    US8181656B2|1998-06-10|2012-05-22|Asthmatx, Inc.|Methods for treating airways|
    US8251070B2|2000-03-27|2012-08-28|Asthmatx, Inc.|Methods for treating airways|
    US6488673B1|1997-04-07|2002-12-03|Broncus Technologies, Inc.|Method of increasing gas exchange of a lung|
    US6045528A|1997-06-13|2000-04-04|Intraear, Inc.|Inner ear fluid transfer and diagnostic system|
    CN1261807A|1997-06-30|2000-08-02|罗纳-布朗克罗莱尔股份有限公司|Improved method for transferring nucleic acid into the striped muscle and combination therefor|
    EP0991425B1|1997-06-30|2005-03-09|Institut Gustave Roussy|Pro|
    US5997532A|1997-07-03|1999-12-07|Cardiac Pathways Corporation|Ablation catheter tip with a buffer layer covering the electrode|
    US6241666B1|1997-07-03|2001-06-05|Cardiac Pathways Corp.|Ablation catheter tip with a buffer layer covering the electrode|
    US6024740A|1997-07-08|2000-02-15|The Regents Of The University Of California|Circumferential ablation device assembly|
    AT353689T|1997-07-16|2007-03-15|Metacure Nv|DEVICE FOR CONTROLLING A SMOOTH MUSCLE|
    US8346363B2|1999-03-05|2013-01-01|Metacure Limited|Blood glucose level control|
    US6010500A|1997-07-21|2000-01-04|Cardiac Pathways Corporation|Telescoping apparatus and method for linear lesion ablation|
    US9023031B2|1997-08-13|2015-05-05|Verathon Inc.|Noninvasive devices, methods, and systems for modifying tissues|
    US5866561A|1997-08-21|1999-02-02|Scimed Life Systems, Inc.|Local delivery of estrogen for angiogenesis|
    US5957901A|1997-10-14|1999-09-28|Merit Medical Systems, Inc.|Catheter with improved spray pattern for pharmaco-mechanical thrombolysis therapy|
    US6042561A|1997-10-22|2000-03-28|Ash Medical Systems, Inc.|Non-intravascular infusion access device|
    WO1999035987A1|1998-01-14|1999-07-22|Conway-Stuart Medical, Inc.|Gerd treatment apparatus and method|
    WO1999035988A1|1998-01-14|1999-07-22|Conway-Stuart Medical, Inc.|Electrosurgical device for sphincter treatment|
    AU2224499A|1998-01-14|1999-08-02|Curon Medical, Inc.|Electrosurgical apparatus for treating gastroesophageal reflux diseaseand method|
    US6159178A|1998-01-23|2000-12-12|Heartport, Inc.|Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested|
    US6802841B2|1998-06-04|2004-10-12|Curon Medical, Inc.|Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction|
    US6790207B2|1998-06-04|2004-09-14|Curon Medical, Inc.|Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract|
    EP1056405A1|1998-02-27|2000-12-06|Curon Medical, Inc.|Apparatus to electrosurgically treat esophageal sphincters|
    US7713297B2|1998-04-11|2010-05-11|Boston Scientific Scimed, Inc.|Drug-releasing stent with ceramic-containing layer|
    US6219577B1|1998-04-14|2001-04-17|Global Vascular Concepts, Inc.|Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues|
    AU3672299A|1998-04-30|1999-11-16|Stuart D Edwards|Electrosurgical sphincter treatment apparatus|
    US6267747B1|1998-05-11|2001-07-31|Cardeon Corporation|Aortic catheter with porous aortic root balloon and methods for inducing cardioplegic arrest|
    IL125424D0|1998-07-20|1999-03-12|New Technologies Sa Ysy Ltd|Pacing with hemodynamic enhancement|
    US6440102B1|1998-07-23|2002-08-27|Durect Corporation|Fluid transfer and diagnostic system for treating the inner ear|
    US8197461B1|1998-12-04|2012-06-12|Durect Corporation|Controlled release system for delivering therapeutic agents into the inner ear|
    US6406455B1|1998-12-18|2002-06-18|Biovalve Technologies, Inc.|Injection devices|
    US6955661B1|1999-01-25|2005-10-18|Atrium Medical Corporation|Expandable fluoropolymer device for delivery of therapeutic agents and method of making|
    AT452181T|1999-02-04|2010-01-15|Pluristem Ltd|METHOD AND DEVICE FOR STABILIZING AND EXPANSIONING HEMATOPOIETIC STEM CELLS AND / OR PRE-PROVIDING CELLS|
    AU767510B2|1999-02-18|2003-11-13|Valeritas, Inc.|Electroactive pore|
    US8019421B2|1999-03-05|2011-09-13|Metacure Limited|Blood glucose level control|
    US9101765B2|1999-03-05|2015-08-11|Metacure Limited|Non-immediate effects of therapy|
    US8666495B2|1999-03-05|2014-03-04|Metacure Limited|Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar|
    US8700161B2|1999-03-05|2014-04-15|Metacure Limited|Blood glucose level control|
    US6792306B2|2000-03-10|2004-09-14|Biophoretic Therapeutic Systems, Llc|Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor|
    DE19912844A1|1999-03-22|2000-09-28|Saphir Medical Products Gmbh|Use of a cutting device, which uses a fluid as cutting medium, for surgical treatment|
    US6047209A|1999-04-02|2000-04-04|Denny; Jeffrey Paul|Method and apparatus for maintenance of pierced orifices|
    US6425877B1|1999-04-02|2002-07-30|Novasys Medical, Inc.|Treatment of tissue in the digestive circulatory respiratory urinary and reproductive systems|
    US6593130B1|1999-04-16|2003-07-15|The Regents Of The University Of California|Method and apparatus for ex vivo and in vivo cellular electroporation of gene protein or drug therapy|
    AU4696100A|1999-05-04|2000-11-17|Curon Medical, Inc.|Electrodes for creating lesions in tissue regions at or near a sphincter|
    US7171263B2|1999-06-04|2007-01-30|Impulse Dynamics Nv|Drug delivery device|
    US7190997B1|1999-06-04|2007-03-13|Impulse Dynamics Nv|Drug delivery device|
    US7092753B2|1999-06-04|2006-08-15|Impulse Dynamics Nv|Drug delivery device|
    WO2000074773A1|1999-06-04|2000-12-14|Impulse Dynamics N.V.|Drug delivery device|
    AT356629T|1999-06-05|2007-04-15|Univ Leland Stanford Junior|METHOD AND COMPOSITION FOR INHIBITING CARDIOVASCULAR CELL PROLIFERATION|
    JP2003523225A|1999-09-08|2003-08-05|キューロンメディカル，インコーポレイテッド|Systems and methods for monitoring and controlling use of medical devices|
    EP1210024A1|1999-09-08|2002-06-05|Curon Medical, Inc.|System for controlling a family of treatment devices|
    US8845632B2|2000-05-18|2014-09-30|Mederi Therapeutics, Inc.|Graphical user interface for monitoring and controlling use of medical devices|
    EP1211984A2|1999-09-08|2002-06-12|Curon Medical, Inc.|Systems and methods for monitoring and controlling use of medical devices|
    US6587718B2|1999-10-08|2003-07-01|Scimed Life Systems, Inc.|Iontophoretic delivery to heart tissue|
    US6993385B1|1999-10-25|2006-01-31|Impulse Dynamics N.V.|Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof|
    AU1049901A|1999-10-25|2001-05-08|Impulse Dynamics N.V.|Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof|
    US7027863B1|1999-10-25|2006-04-11|Impulse Dynamics N.V.|Device for cardiac therapy|
    CA2825425C|1999-11-16|2016-03-22|Covidien Lp|System and method of treating abnormal tissue in the human esophagus|
    US20040215235A1|1999-11-16|2004-10-28|Barrx, Inc.|Methods and systems for determining physiologic characteristics for treatment of the esophagus|
    US20060095032A1|1999-11-16|2006-05-04|Jerome Jackson|Methods and systems for determining physiologic characteristics for treatment of the esophagus|
    US6547776B1|2000-01-03|2003-04-15|Curon Medical, Inc.|Systems and methods for treating tissue in the crura|
    US7184827B1|2000-01-24|2007-02-27|Stuart D. Edwards|Shrinkage of dilatations in the body|
    US7306591B2|2000-10-02|2007-12-11|Novasys Medical, Inc.|Apparatus and methods for treating female urinary incontinence|
    US6640120B1|2000-10-05|2003-10-28|Scimed Life Systems, Inc.|Probe assembly for mapping and ablating pulmonary vein tissue and method of using same|
    US7198635B2|2000-10-17|2007-04-03|Asthmatx, Inc.|Modification of airways by application of energy|
    US7104987B2|2000-10-17|2006-09-12|Asthmatx, Inc.|Control system and process for application of energy to airway walls and other mediums|
    DE10129285C2|2001-06-18|2003-01-09|Hans-Joachim Mueschenborn|Encryption procedure with arbitrary selectable one-time keys|
    US7727221B2|2001-06-27|2010-06-01|Cardiac Pacemakers Inc.|Method and device for electrochemical formation of therapeutic species in vivo|
    FR2830767B1|2001-10-12|2004-03-12|Optis France Sa|DEVICE FOR DELIVERING DRUGS BY IONTOPHORESIS OR INTROCULAR ELECTROPORATION|
    US7488313B2|2001-11-29|2009-02-10|Boston Scientific Scimed, Inc.|Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment|
    DE10205373B4|2002-02-09|2007-07-19|Aloys Wobben|Fire protection|
    US8347891B2|2002-04-08|2013-01-08|Medtronic Ardian Luxembourg S.A.R.L.|Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen|
    US20070135875A1|2002-04-08|2007-06-14|Ardian, Inc.|Methods and apparatus for thermally-induced renal neuromodulation|
    US7756583B2|2002-04-08|2010-07-13|Ardian, Inc.|Methods and apparatus for intravascularly-induced neuromodulation|
    US8150519B2|2002-04-08|2012-04-03|Ardian, Inc.|Methods and apparatus for bilateral renal neuromodulation|
    US7617005B2|2002-04-08|2009-11-10|Ardian, Inc.|Methods and apparatus for thermally-induced renal neuromodulation|
    US20080213331A1|2002-04-08|2008-09-04|Ardian, Inc.|Methods and devices for renal nerve blocking|
    US20070129761A1|2002-04-08|2007-06-07|Ardian, Inc.|Methods for treating heart arrhythmia|
    US9636174B2|2002-04-08|2017-05-02|Medtronic Ardian Luxembourg S.A.R.L.|Methods for therapeutic renal neuromodulation|
    CN100538292C|2003-02-10|2009-09-09|N-特莱格有限公司|The touch of Aristogrid detects|
    US8352031B2|2004-03-10|2013-01-08|Impulse Dynamics Nv|Protein activity modification|
    JP2006519663A|2003-03-10|2006-08-31|インパルスダイナミックスエヌヴイ|Apparatus and method for delivering electrical signals for regulating gene expression in heart tissue|
    US20040226556A1|2003-05-13|2004-11-18|Deem Mark E.|Apparatus for treating asthma using neurotoxin|
    US20040236308A1|2003-05-22|2004-11-25|Atrium Medical Corp.|Kinetic isolation pressurization|
    US8792985B2|2003-07-21|2014-07-29|Metacure Limited|Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar|
    US9713730B2|2004-09-10|2017-07-25|Boston Scientific Scimed, Inc.|Apparatus and method for treatment of in-stent restenosis|
    CA2539026C|2003-09-12|2016-10-04|Minnow Medical, Llc|Selectable eccentric remodeling and/or ablation of atherosclerotic material|
    US7736362B2|2003-09-15|2010-06-15|Boston Scientific Scimed, Inc.|Catheter balloons|
    US7150745B2|2004-01-09|2006-12-19|Barrx Medical, Inc.|Devices and methods for treatment of luminal tissue|
    US7922740B2|2004-02-24|2011-04-12|Boston Scientific Scimed, Inc.|Rotatable catheter assembly|
    US7744619B2|2004-02-24|2010-06-29|Boston Scientific Scimed, Inc.|Rotatable catheter assembly|
    WO2005084301A2|2004-03-01|2005-09-15|Lumen Therapeutics, Llc|Compositions and methods for treating diseases|
    US9821158B2|2005-02-17|2017-11-21|Metacure Limited|Non-immediate effects of therapy|
    EP1827571B1|2004-12-09|2016-09-07|Impulse Dynamics NV|Protein activity modification|
    WO2006097934A2|2005-03-18|2006-09-21|Metacure Limited|Pancreas lead|
    US20050209548A1|2004-03-19|2005-09-22|Dev Sukhendu B|Electroporation-mediated intravascular delivery|
    US8337482B2|2004-04-19|2012-12-25|The Invention Science Fund I, Llc|System for perfusion management|
    US8353896B2|2004-04-19|2013-01-15|The Invention Science Fund I, Llc|Controllable release nasal system|
    US8019413B2|2007-03-19|2011-09-13|The Invention Science Fund I, Llc|Lumen-traveling biological interface device and method of use|
    US7850676B2|2004-04-19|2010-12-14|The Invention Science Fund I, Llc|System with a reservoir for perfusion management|
    US7998060B2|2004-04-19|2011-08-16|The Invention Science Fund I, Llc|Lumen-traveling delivery device|
    US8512219B2|2004-04-19|2013-08-20|The Invention Science Fund I, Llc|Bioelectromagnetic interface system|
    US20120035439A1|2006-04-12|2012-02-09|Bran Ferren|Map-based navigation of a body tube tree by a lumen traveling device|
    US8361013B2|2004-04-19|2013-01-29|The Invention Science Fund I, Llc|Telescoping perfusion management system|
    US9011329B2|2004-04-19|2015-04-21|Searete Llc|Lumenally-active device|
    US8000784B2|2004-04-19|2011-08-16|The Invention Science Fund I, Llc|Lumen-traveling device|
    US7706873B2|2004-05-05|2010-04-27|Mario Ammirati|System and method for controlled delivery of a therapeutic agent to a target location within an internal body tissue|
    US8092549B2|2004-09-24|2012-01-10|The Invention Science Fund I, Llc|Ciliated stent-like-system|
    US20060085058A1|2004-10-20|2006-04-20|Rosenthal Arthur L|System and method for delivering a biologically active material to a body lumen|
    WO2006052940A2|2004-11-05|2006-05-18|Asthmatx, Inc.|Medical device with procedure improvement features|
    US7949407B2|2004-11-05|2011-05-24|Asthmatx, Inc.|Energy delivery devices and methods|
    EP1898991B1|2005-05-04|2016-06-29|Impulse Dynamics NV|Protein activity modification|
    US7803168B2|2004-12-09|2010-09-28|The Foundry, Llc|Aortic valve repair|
    US8137333B2|2005-10-25|2012-03-20|Voyage Medical, Inc.|Delivery of biological compounds to ischemic and/or infarcted tissue|
    US7930016B1|2005-02-02|2011-04-19|Voyage Medical, Inc.|Tissue closure system|
    US7860555B2|2005-02-02|2010-12-28|Voyage Medical, Inc.|Tissue visualization and manipulation system|
    US8050746B2|2005-02-02|2011-11-01|Voyage Medical, Inc.|Tissue visualization device and method variations|
    US8221310B2|2005-10-25|2012-07-17|Voyage Medical, Inc.|Tissue visualization device and method variations|
    US7860556B2|2005-02-02|2010-12-28|Voyage Medical, Inc.|Tissue imaging and extraction systems|
    US9510732B2|2005-10-25|2016-12-06|Intuitive Surgical Operations, Inc.|Methods and apparatus for efficient purging|
    US9055906B2|2006-06-14|2015-06-16|Intuitive Surgical Operations, Inc.|In-vivo visualization systems|
    US8078266B2|2005-10-25|2011-12-13|Voyage Medical, Inc.|Flow reduction hood systems|
    US10064540B2|2005-02-02|2018-09-04|Intuitive Surgical Operations, Inc.|Visualization apparatus for transseptal access|
    US7918787B2|2005-02-02|2011-04-05|Voyage Medical, Inc.|Tissue visualization and manipulation systems|
    US20120149985A1|2007-05-18|2012-06-14|Frassica James J|Rotate-to-advance catheterization system|
    SE0501077L|2005-05-12|2006-11-13|Spectracure Ab|Device for photodynamic diagnosis or treatment|
    WO2006133193A1|2005-06-07|2006-12-14|American Medical Systems Research Corporation|Injection guidance system and method|
    JP2007000342A|2005-06-23|2007-01-11|Transcutaneous Technologies Inc|Iontophoresis device for controlling quantity and time of dosing a plurality of medicaments|
    US8295922B2|2005-08-08|2012-10-23|Tti Ellebeau, Inc.|Iontophoresis device|
    US8386030B2|2005-08-08|2013-02-26|Tti Ellebeau, Inc.|Iontophoresis device|
    US20070088332A1|2005-08-22|2007-04-19|Transcutaneous Technologies Inc.|Iontophoresis device|
    WO2007023907A1|2005-08-24|2007-03-01|Transcu Ltd.|Refrigeration-type electrode structure for iontophoresis|
    WO2007026672A1|2005-08-29|2007-03-08|Transcu Ltd.|General-purpose electrolyte composition for iontophoresis|
    WO2007029611A1|2005-09-06|2007-03-15|Tti Ellebeau, Inc.|Iontophoresis device|
    US20070112294A1|2005-09-14|2007-05-17|Transcutaneous Technologies Inc.|Iontophoresis device|
    CA2619665A1|2005-09-15|2007-03-22|Tti Ellebeau, Inc.|Rod type iontophoresis device|
    US20070078374A1|2005-09-30|2007-04-05|Transcutaneous Technologies Inc.|Iontophoretic delivery of vesicle-encapsulated active agents|
    JP2009509685A|2005-09-30|2009-03-12|Ｔｔｉ・エルビュー株式会社|Iontophoresis device and method for delivery of angiogenic factors to enhance healing of damaged tissue|
    JPWO2007037476A1|2005-09-30|2009-04-16|Ｔｔｉ・エルビュー株式会社|Iontophoresis device for controlling the dosage and timing of sleep inducers and stimulants|
    WO2007041115A1|2005-09-30|2007-04-12|Tti Ellebeau Inc.|Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces|
    US20070093802A1|2005-10-21|2007-04-26|Danek Christopher J|Energy delivery devices and methods|
    US7997278B2|2005-11-23|2011-08-16|Barrx Medical, Inc.|Precision ablating method|
    US8702694B2|2005-11-23|2014-04-22|Covidien Lp|Auto-aligning ablating device and method of use|
    US7959627B2|2005-11-23|2011-06-14|Barrx Medical, Inc.|Precision ablating device|
    US8840660B2|2006-01-05|2014-09-23|Boston Scientific Scimed, Inc.|Bioerodible endoprostheses and methods of making the same|
    US8089029B2|2006-02-01|2012-01-03|Boston Scientific Scimed, Inc.|Bioabsorbable metal medical device and method of manufacture|
    US20070224235A1|2006-03-24|2007-09-27|Barron Tenney|Medical devices having nanoporous coatings for controlled therapeutic agent delivery|
    US8187620B2|2006-03-27|2012-05-29|Boston Scientific Scimed, Inc.|Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents|
    US8888684B2|2006-03-27|2014-11-18|Boston Scientific Scimed, Inc.|Medical devices with local drug delivery capabilities|
    US8048150B2|2006-04-12|2011-11-01|Boston Scientific Scimed, Inc.|Endoprosthesis having a fiber meshwork disposed thereon|
    US8019435B2|2006-05-02|2011-09-13|Boston Scientific Scimed, Inc.|Control of arterial smooth muscle tone|
    US8815275B2|2006-06-28|2014-08-26|Boston Scientific Scimed, Inc.|Coatings for medical devices comprising a therapeutic agent and a metallic material|
    JP2009542359A|2006-06-29|2009-12-03|ボストンサイエンティフィックリミテッド|Medical device with selective covering|
    KR20090045916A|2006-07-03|2009-05-08|헤모텍 아게|Manufacture, method and use of drug-eluting medical devices for permanently keeping blood vessels open|
    US9192697B2|2007-07-03|2015-11-24|Hemoteq Ag|Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis|
    CA2659761A1|2006-08-02|2008-02-07|Boston Scientific Scimed, Inc.|Endoprosthesis with three-dimensional disintegration control|
    US20080097476A1|2006-09-01|2008-04-24|Voyage Medical, Inc.|Precision control systems for tissue visualization and manipulation assemblies|
    JP2010502313A|2006-09-01|2010-01-28|ボエッジメディカル，インコーポレイテッド|Method and apparatus for the treatment of atrial fibrillation|
    US10004388B2|2006-09-01|2018-06-26|Intuitive Surgical Operations, Inc.|Coronary sinus cannulation|
    US8260411B1|2006-09-06|2012-09-04|Twin Star Medical, Inc.|Conductive injection and aspiration device and method|
    AT508708T|2006-09-14|2011-05-15|Boston Scient Ltd|MEDICAL DEVICES WITH ACTIVE EXTRACTION COATING|
    EP2068964B1|2006-09-15|2017-11-01|Boston Scientific Limited|Medical devices and methods of making the same|
    WO2008034048A2|2006-09-15|2008-03-20|Boston Scientific Limited|Bioerodible endoprosthesis with biostable inorganic layers|
    US8808726B2|2006-09-15|2014-08-19|Boston Scientific Scimed. Inc.|Bioerodible endoprostheses and methods of making the same|
    AT517590T|2006-09-15|2011-08-15|Boston Scient Ltd|BIODEGRADABLE ENDOPROTHESES|
    CA2663762A1|2006-09-18|2008-03-27|Boston Scientific Limited|Endoprostheses|
    EP2076193A4|2006-10-18|2010-02-03|Minnow Medical Inc|Tuned rf energy and electrical tissue characterization for selective treatment of target tissues|
    EP2455034B1|2006-10-18|2017-07-19|Vessix Vascular, Inc.|System for inducing desirable temperature effects on body tissue|
    CA2666660C|2006-10-18|2015-06-02|Minnow Medical, Inc.|Inducing desirable temperature effects on body tissue|
    US7931647B2|2006-10-20|2011-04-26|Asthmatx, Inc.|Method of delivering energy to a lung airway using markers|
    US10335131B2|2006-10-23|2019-07-02|Intuitive Surgical Operations, Inc.|Methods for preventing tissue migration|
    US7981150B2|2006-11-09|2011-07-19|Boston Scientific Scimed, Inc.|Endoprosthesis with coatings|
    BRPI0719353A2|2006-12-01|2014-01-07|Titi Ellebeau Inc|SYSTEMS, DEVICES AND METHODS FOR ENERGIZATION AND / OR CONTROL DEVICES, FOR EXAMPLE, TRANSDERMIC DISTRIBUTION DEVICES|
    US20080183036A1|2006-12-18|2008-07-31|Voyage Medical, Inc.|Systems and methods for unobstructed visualization and ablation|
    US8131350B2|2006-12-21|2012-03-06|Voyage Medical, Inc.|Stabilization of visualization catheters|
    US9226648B2|2006-12-21|2016-01-05|Intuitive Surgical Operations, Inc.|Off-axis visualization systems|
    US8080055B2|2006-12-28|2011-12-20|Boston Scientific Scimed, Inc.|Bioerodible endoprostheses and methods of making the same|
    EP2136853B1|2007-01-21|2013-04-10|Hemoteq AG|Medical product for treating stenosis of body passages and for preventing threatening restenosis|
    US8431149B2|2007-03-01|2013-04-30|Boston Scientific Scimed, Inc.|Coated medical devices for abluminal drug delivery|
    US8070797B2|2007-03-01|2011-12-06|Boston Scientific Scimed, Inc.|Medical device with a porous surface for delivery of a therapeutic agent|
    US8067054B2|2007-04-05|2011-11-29|Boston Scientific Scimed, Inc.|Stents with ceramic drug reservoir layer and methods of making and using the same|
    US8496653B2|2007-04-23|2013-07-30|Boston Scientific Scimed, Inc.|Thrombus removal|
    JP2010524651A|2007-04-27|2010-07-22|ボエッジメディカル，インコーポレイテッド|Complex shape steerable tissue visualization and manipulation catheter|
    WO2008137757A1|2007-05-04|2008-11-13|Barrx Medical, Inc.|Method and apparatus for gastrointestinal tract ablation for treatment of obesity|
    US8657805B2|2007-05-08|2014-02-25|Intuitive Surgical Operations, Inc.|Complex shape steerable tissue visualization and manipulation catheter|
    US8709008B2|2007-05-11|2014-04-29|Intuitive Surgical Operations, Inc.|Visual electrode ablation systems|
    US7976915B2|2007-05-23|2011-07-12|Boston Scientific Scimed, Inc.|Endoprosthesis with select ceramic morphology|
    US8784338B2|2007-06-22|2014-07-22|Covidien Lp|Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size|
    EP2173412A4|2007-07-06|2011-07-27|Allievion Medical Inc|Constrained fluid delivery device|
    WO2009009443A1|2007-07-06|2009-01-15|Barrx Medical, Inc.|Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation|
    AU2008275316B2|2007-07-06|2013-11-14|Covidien Lp|Ablation in the gastrointestinal tract to achieve hemostasis and eradicate lesions with a propensity for bleeding|
    US8002823B2|2007-07-11|2011-08-23|Boston Scientific Scimed, Inc.|Endoprosthesis coating|
    US7942926B2|2007-07-11|2011-05-17|Boston Scientific Scimed, Inc.|Endoprosthesis coating|
    US8235983B2|2007-07-12|2012-08-07|Asthmatx, Inc.|Systems and methods for delivering energy to passageways in a patient|
    US9284409B2|2007-07-19|2016-03-15|Boston Scientific Scimed, Inc.|Endoprosthesis having a non-fouling surface|
    US7931683B2|2007-07-27|2011-04-26|Boston Scientific Scimed, Inc.|Articles having ceramic coated surfaces|
    US8815273B2|2007-07-27|2014-08-26|Boston Scientific Scimed, Inc.|Drug eluting medical devices having porous layers|
    US8273012B2|2007-07-30|2012-09-25|Tyco Healthcare Group, Lp|Cleaning device and methods|
    US8646460B2|2007-07-30|2014-02-11|Covidien Lp|Cleaning device and methods|
    WO2009018340A2|2007-07-31|2009-02-05|Boston Scientific Scimed, Inc.|Medical device coating by laser cladding|
    JP2010535541A|2007-08-03|2010-11-25|ボストンサイエンティフィックリミテッド|Coating for medical devices with large surface area|
    US8235985B2|2007-08-31|2012-08-07|Voyage Medical, Inc.|Visualization and ablation system variations|
    US8182446B2|2007-09-12|2012-05-22|Cook Medical Technologies|Balloon catheter for delivering a therapeutic agent|
    US20110137245A1|2007-09-12|2011-06-09|Cook Medical Technologies Llc|Balloon catheter with embedded rod|
    US8052745B2|2007-09-13|2011-11-08|Boston Scientific Scimed, Inc.|Endoprosthesis|
    US8216632B2|2007-11-02|2012-07-10|Boston Scientific Scimed, Inc.|Endoprosthesis coating|
    US7938855B2|2007-11-02|2011-05-10|Boston Scientific Scimed, Inc.|Deformable underlayer for stent|
    US8029554B2|2007-11-02|2011-10-04|Boston Scientific Scimed, Inc.|Stent with embedded material|
    US8858609B2|2008-02-07|2014-10-14|Intuitive Surgical Operations, Inc.|Stent delivery under direct visualization|
    US8483831B1|2008-02-15|2013-07-09|Holaira, Inc.|System and method for bronchial dilation|
    US8034022B2|2008-04-08|2011-10-11|Cook Medical Technologies Llc|Weeping balloon catheter|
    WO2009131911A2|2008-04-22|2009-10-29|Boston Scientific Scimed, Inc.|Medical devices having a coating of inorganic material|
    US8932346B2|2008-04-24|2015-01-13|Boston Scientific Scimed, Inc.|Medical devices having inorganic particle layers|
    US7998192B2|2008-05-09|2011-08-16|Boston Scientific Scimed, Inc.|Endoprostheses|
    WO2009137819A1|2008-05-09|2009-11-12|Innovative Pulmonary Solutions, Inc.|Systems, assemblies, and methods for treating a bronchial tree|
    US7873404B1|2008-05-29|2011-01-18|Seth Caplan|Method for performing angioplasty and angiography with a single catheter|
    US8236046B2|2008-06-10|2012-08-07|Boston Scientific Scimed, Inc.|Bioerodible endoprosthesis|
    US8449603B2|2008-06-18|2013-05-28|Boston Scientific Scimed, Inc.|Endoprosthesis coating|
    US9101735B2|2008-07-07|2015-08-11|Intuitive Surgical Operations, Inc.|Catheter control systems|
    WO2010006483A1|2008-07-18|2010-01-21|圣太科医疗科技（上海）有限公司|An apparatus of low strength electric field network-mediated delivery of drug to target cell of liver|
    US7985252B2|2008-07-30|2011-07-26|Boston Scientific Scimed, Inc.|Bioerodible endoprosthesis|
    US8840602B2|2008-07-31|2014-09-23|Acclarent, Inc.|Systems and methods for anesthetizing ear tissue|
    US8133199B2|2008-08-27|2012-03-13|Boston Scientific Scimed, Inc.|Electroactive polymer activation system for a medical device|
    US8382824B2|2008-10-03|2013-02-26|Boston Scientific Scimed, Inc.|Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides|
    US8333012B2|2008-10-10|2012-12-18|Voyage Medical, Inc.|Method of forming electrode placement and connection systems|
    US8894643B2|2008-10-10|2014-11-25|Intuitive Surgical Operations, Inc.|Integral electrode placement and connection systems|
    US9468364B2|2008-11-14|2016-10-18|Intuitive Surgical Operations, Inc.|Intravascular catheter with hood and image processing systems|
    US8396548B2|2008-11-14|2013-03-12|Vessix Vascular, Inc.|Selective drug delivery in a lumen|
    KR20110104504A|2008-11-17|2011-09-22|미노우 메디컬, 인코포레이티드|Selective accumulation of energy with or without knowledge of tissue topography|
    US8231980B2|2008-12-03|2012-07-31|Boston Scientific Scimed, Inc.|Medical implants including iridium oxide|
    US8923970B2|2008-12-09|2014-12-30|Nephera Ltd.|Stimulation of the urinary system|
    US8725249B2|2008-12-09|2014-05-13|Nephera Ltd.|Stimulation of the urinary system|
    US20100160906A1|2008-12-23|2010-06-24|Asthmatx, Inc.|Expandable energy delivery devices having flexible conductive elements and associated systems and methods|
    EP2403546A2|2009-03-02|2012-01-11|Boston Scientific Scimed, Inc.|Self-buffering medical implants|
    US8071156B2|2009-03-04|2011-12-06|Boston Scientific Scimed, Inc.|Endoprostheses|
    US8287937B2|2009-04-24|2012-10-16|Boston Scientific Scimed, Inc.|Endoprosthese|
    US20100272773A1|2009-04-24|2010-10-28|Boston Scientific Scimed, Inc.|Use of Drug Polymorphs to Achieve Controlled Drug Delivery From a Coated Medical Device|
    US8551096B2|2009-05-13|2013-10-08|Boston Scientific Scimed, Inc.|Directional delivery of energy and bioactives|
    WO2010144424A2|2009-06-09|2010-12-16|Tti Ellebeau, Inc.|Long life high capacity electrode, device, and method of manufacture|
    JP2012532670A|2009-07-10|2012-12-20|ボストンサイエンティフィックサイムド，インコーポレイテッド|Use of nanocrystals for drug delivery balloons|
    US10080821B2|2009-07-17|2018-09-25|Boston Scientific Scimed, Inc.|Nucleation of drug delivery balloons to provide improved crystal size and density|
    US8221396B2|2009-08-27|2012-07-17|Silver Bullet Therapeutics, Inc.|Bone implants for the treatment of infection|
    US10265435B2|2009-08-27|2019-04-23|Silver Bullet Therapeutics, Inc.|Bone implant and systems and coatings for the controllable release of antimicrobial metal ions|
    US9474565B2|2009-09-22|2016-10-25|Mederi Therapeutics, Inc.|Systems and methods for treating tissue with radiofrequency energy|
    WO2011037621A2|2009-09-22|2011-03-31|Mederi Therapeutics Inc.|Systems and methods for controlling use and operation of a family of different treatment devices|
    US9750563B2|2009-09-22|2017-09-05|Mederi Therapeutics, Inc.|Systems and methods for treating tissue with radiofrequency energy|
    US9775664B2|2009-09-22|2017-10-03|Mederi Therapeutics, Inc.|Systems and methods for treating tissue with radiofrequency energy|
    US10386990B2|2009-09-22|2019-08-20|Mederi Rf, Llc|Systems and methods for treating tissue with radiofrequency energy|
    CA2779135C|2009-10-27|2018-09-04|Innovative Pulmonary Solutions, Inc.|Delivery devices with coolable energy emitting assemblies|
    CN102711645B|2009-11-11|2016-12-28|赫莱拉公司|For processing tissue and controlling narrow system and device|
    US8911439B2|2009-11-11|2014-12-16|Holaira, Inc.|Non-invasive and minimally invasive denervation methods and systems for performing the same|
    WO2011092710A2|2010-02-01|2011-08-04|Metacure Limited|Gastrointestinal electrical therapy|
    US8694071B2|2010-02-12|2014-04-08|Intuitive Surgical Operations, Inc.|Image stabilization techniques and methods|
    WO2011119573A1|2010-03-23|2011-09-29|Boston Scientific Scimed, Inc.|Surface treated bioerodible metal endoprostheses|
    US9814522B2|2010-04-06|2017-11-14|Intuitive Surgical Operations, Inc.|Apparatus and methods for ablation efficacy|
    EP2555699B1|2010-04-09|2019-04-03|Vessix Vascular, Inc.|Power generating and control apparatus for the treatment of tissue|
    US9192790B2|2010-04-14|2015-11-24|Boston Scientific Scimed, Inc.|Focused ultrasonic renal denervation|
    US8473067B2|2010-06-11|2013-06-25|Boston Scientific Scimed, Inc.|Renal denervation and stimulation employing wireless vascular energy transfer arrangement|
    US9463062B2|2010-07-30|2016-10-11|Boston Scientific Scimed, Inc.|Cooled conductive balloon RF catheter for renal nerve ablation|
    US9408661B2|2010-07-30|2016-08-09|Patrick A. Haverkost|RF electrodes on multiple flexible wires for renal nerve ablation|
    US9155589B2|2010-07-30|2015-10-13|Boston Scientific Scimed, Inc.|Sequential activation RF electrode set for renal nerve ablation|
    US9084609B2|2010-07-30|2015-07-21|Boston Scientific Scime, Inc.|Spiral balloon catheter for renal nerve ablation|
    US9358365B2|2010-07-30|2016-06-07|Boston Scientific Scimed, Inc.|Precision electrode movement control for renal nerve ablation|
    US8889211B2|2010-09-02|2014-11-18|Boston Scientific Scimed, Inc.|Coating process for drug delivery balloons using heat-induced rewrap memory|
    US9265913B2|2010-09-22|2016-02-23|Vital 5, Llc|Catheter assembly|
    US9446224B2|2010-09-22|2016-09-20|Vital 5, L.L.C.|Barrier catheter|
    US8974451B2|2010-10-25|2015-03-10|Boston Scientific Scimed, Inc.|Renal nerve ablation using conductive fluid jet and RF energy|
    US9220558B2|2010-10-27|2015-12-29|Boston Scientific Scimed, Inc.|RF renal denervation catheter with multiple independent electrodes|
    WO2012064402A1|2010-11-12|2012-05-18|Silver Bullet Therapeutics, Inc.|Bone implant and systems that controllably releases silver|
    US9028485B2|2010-11-15|2015-05-12|Boston Scientific Scimed, Inc.|Self-expanding cooling electrode for renal nerve ablation|
    US9668811B2|2010-11-16|2017-06-06|Boston Scientific Scimed, Inc.|Minimally invasive access for renal nerve ablation|
    US9089350B2|2010-11-16|2015-07-28|Boston Scientific Scimed, Inc.|Renal denervation catheter with RF electrode and integral contrast dye injection arrangement|
    US9326751B2|2010-11-17|2016-05-03|Boston Scientific Scimed, Inc.|Catheter guidance of external energy for renal denervation|
    US9060761B2|2010-11-18|2015-06-23|Boston Scientific Scime, Inc.|Catheter-focused magnetic field induced renal nerve ablation|
    US9192435B2|2010-11-22|2015-11-24|Boston Scientific Scimed, Inc.|Renal denervation catheter with cooled RF electrode|
    US9023034B2|2010-11-22|2015-05-05|Boston Scientific Scimed, Inc.|Renal ablation electrode with force-activatable conduction apparatus|
    US20120157993A1|2010-12-15|2012-06-21|Jenson Mark L|Bipolar Off-Wall Electrode Device for Renal Nerve Ablation|
    WO2012100095A1|2011-01-19|2012-07-26|Boston Scientific Scimed, Inc.|Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury|
    US10278774B2|2011-03-18|2019-05-07|Covidien Lp|Selectively expandable operative element support structure and methods of use|
    CN103517731B|2011-04-08|2016-08-31|柯惠有限合伙公司|For removing iontophoresis formula drug delivery system and the method for renal sympathetic nerve and iontophoresis formula drug delivery|
    EP2701623B1|2011-04-25|2016-08-17|Medtronic Ardian Luxembourg S.à.r.l.|Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls|
    EP2734259B1|2011-07-20|2016-11-23|Boston Scientific Scimed, Inc.|Percutaneous device to visualize, target and ablate nerves|
    JP6106669B2|2011-07-22|2017-04-05|ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ．|A neuromodulation system having a neuromodulation element that can be placed in a helical guide|
    WO2013022458A1|2011-08-05|2013-02-14|Boston Scientific Scimed, Inc.|Methods of converting amorphous drug substance into crystalline form|
    US9056152B2|2011-08-25|2015-06-16|Boston Scientific Scimed, Inc.|Medical device with crystalline drug coating|
    WO2013055826A1|2011-10-10|2013-04-18|Boston Scientific Scimed, Inc.|Medical devices including ablation electrodes|
    US9420955B2|2011-10-11|2016-08-23|Boston Scientific Scimed, Inc.|Intravascular temperature monitoring system and method|
    WO2013055815A1|2011-10-11|2013-04-18|Boston Scientific Scimed, Inc.|Off -wall electrode device for nerve modulation|
    US9364284B2|2011-10-12|2016-06-14|Boston Scientific Scimed, Inc.|Method of making an off-wall spacer cage|
    WO2013059202A1|2011-10-18|2013-04-25|Boston Scientific Scimed, Inc.|Integrated crossing balloon catheter|
    EP2768563B1|2011-10-18|2016-11-09|Boston Scientific Scimed, Inc.|Deflectable medical devices|
    CN108095821B|2011-11-08|2021-05-25|波士顿科学西美德公司|Orifice renal nerve ablation|
    US9119600B2|2011-11-15|2015-09-01|Boston Scientific Scimed, Inc.|Device and methods for renal nerve modulation monitoring|
    US9119632B2|2011-11-21|2015-09-01|Boston Scientific Scimed, Inc.|Deflectable renal nerve ablation catheter|
    US9265969B2|2011-12-21|2016-02-23|Cardiac Pacemakers, Inc.|Methods for modulating cell function|
    CA2859989C|2011-12-23|2020-03-24|Vessix Vascular, Inc.|Methods and apparatuses for remodeling tissue of or adjacent to a body passage|
    CN104135958B|2011-12-28|2017-05-03|波士顿科学西美德公司|By the apparatus and method that have the new ablation catheter modulation nerve of polymer ablation|
    US9050106B2|2011-12-29|2015-06-09|Boston Scientific Scimed, Inc.|Off-wall electrode device and methods for nerve modulation|
    US8403927B1|2012-04-05|2013-03-26|William Bruce Shingleton|Vasectomy devices and methods|
    WO2013169927A1|2012-05-08|2013-11-14|Boston Scientific Scimed, Inc.|Renal nerve modulation devices|
    EP2854682B1|2012-06-04|2021-06-23|Boston Scientific Scimed, Inc.|Systems for treating tissue of a passageway within a body|
    US9256531B2|2012-06-19|2016-02-09|Samsung Electronics Co., Ltd.|Memory system and SoC including linear addresss remapping logic|
    WO2014018153A1|2012-07-24|2014-01-30|Boston Scientific Scimed, Inc.|Electrodes for tissue treatment|
    US10321946B2|2012-08-24|2019-06-18|Boston Scientific Scimed, Inc.|Renal nerve modulation devices with weeping RF ablation balloons|
    US9173696B2|2012-09-17|2015-11-03|Boston Scientific Scimed, Inc.|Self-positioning electrode system and method for renal nerve modulation|
    WO2014047454A2|2012-09-21|2014-03-27|Boston Scientific Scimed, Inc.|Self-cooling ultrasound ablation catheter|
    WO2014047411A1|2012-09-21|2014-03-27|Boston Scientific Scimed, Inc.|System for nerve modulation and innocuous thermal gradient nerve block|
    CN104869930B|2012-10-10|2020-12-25|波士顿科学国际有限公司|Renal neuromodulation apparatus and methods|
    US9272132B2|2012-11-02|2016-03-01|Boston Scientific Scimed, Inc.|Medical device for treating airways and related methods of use|
    WO2014071372A1|2012-11-05|2014-05-08|Boston Scientific Scimed, Inc.|Devices for delivering energy to body lumens|
    US10286182B2|2012-11-12|2019-05-14|Boston Scientific Scimed, Inc.|Renal catheter shaft design|
    US9398933B2|2012-12-27|2016-07-26|Holaira, Inc.|Methods for improving drug efficacy including a combination of drug administration and nerve modulation|
    US9693821B2|2013-03-11|2017-07-04|Boston Scientific Scimed, Inc.|Medical devices for modulating nerves|
    US9956033B2|2013-03-11|2018-05-01|Boston Scientific Scimed, Inc.|Medical devices for modulating nerves|
    US9808311B2|2013-03-13|2017-11-07|Boston Scientific Scimed, Inc.|Deflectable medical devices|
    US9669194B2|2013-03-14|2017-06-06|W. L. Gore & Associates, Inc.|Conformable balloon devices and methods|
    US10265122B2|2013-03-15|2019-04-23|Boston Scientific Scimed, Inc.|Nerve ablation devices and related methods of use|
    US9297845B2|2013-03-15|2016-03-29|Boston Scientific Scimed, Inc.|Medical devices and methods for treatment of hypertension that utilize impedance compensation|
    CN105473090B|2013-03-15|2019-05-03|波士顿科学国际有限公司|Rebuild the method and device of the tissue of body passage or the tissue of neighbouring body passage|
    US9814618B2|2013-06-06|2017-11-14|Boston Scientific Scimed, Inc.|Devices for delivering energy and related methods of use|
    US10022182B2|2013-06-21|2018-07-17|Boston Scientific Scimed, Inc.|Medical devices for renal nerve ablation having rotatable shafts|
    CN105473091B|2013-06-21|2020-01-21|波士顿科学国际有限公司|Renal denervation balloon catheter with co-movable electrode supports|
    US9707036B2|2013-06-25|2017-07-18|Boston Scientific Scimed, Inc.|Devices and methods for nerve modulation using localized indifferent electrodes|
    WO2015002787A1|2013-07-01|2015-01-08|Boston Scientific Scimed, Inc.|Medical devices for renal nerve ablation|
    EP3019106A1|2013-07-11|2016-05-18|Boston Scientific Scimed, Inc.|Medical device with stretchable electrode assemblies|
    US10660698B2|2013-07-11|2020-05-26|Boston Scientific Scimed, Inc.|Devices and methods for nerve modulation|
    CN105682594B|2013-07-19|2018-06-22|波士顿科学国际有限公司|Helical bipolar electrodes renal denervation dominates air bag|
    CN105392435B|2013-07-22|2018-11-09|波士顿科学国际有限公司|Renal nerve ablation catheter with twisting sacculus|
    US10342609B2|2013-07-22|2019-07-09|Boston Scientific Scimed, Inc.|Medical devices for renal nerve ablation|
    US10478247B2|2013-08-09|2019-11-19|Boston Scientific Scimed, Inc.|Expandable catheter and related methods of manufacture and use|
    CN105473093B|2013-08-22|2019-02-05|波士顿科学国际有限公司|Flexible circuit with the improved adhesion strength to renal nerve modulation sacculus|
    CN105555218B|2013-09-04|2019-01-15|波士顿科学国际有限公司|With radio frequencyfoley's tube rinsed with cooling capacity|
    CN105530885B|2013-09-13|2020-09-22|波士顿科学国际有限公司|Ablation balloon with vapor deposited covering|
    US9687166B2|2013-10-14|2017-06-27|Boston Scientific Scimed, Inc.|High resolution cardiac mapping electrode array catheter|
    EP3057520A1|2013-10-15|2016-08-24|Boston Scientific Scimed, Inc.|Medical device balloon|
    US9770606B2|2013-10-15|2017-09-26|Boston Scientific Scimed, Inc.|Ultrasound ablation catheter with cooling infusion and centering basket|
    JP6259099B2|2013-10-18|2018-01-10|ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ．|Balloon catheter comprising a conductive wire with flexibility, and related uses and manufacturing methods|
    JP2016534842A|2013-10-25|2016-11-10|ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ．|Embedded thermocouples in denervation flex circuits|
    US10286190B2|2013-12-11|2019-05-14|Cook Medical Technologies Llc|Balloon catheter with dynamic vessel engaging member|
    EP3091922B1|2014-01-06|2018-10-17|Boston Scientific Scimed, Inc.|Tear resistant flex circuit assembly|
    EP2898920B1|2014-01-24|2018-06-06|Cook Medical Technologies LLC|Articulating balloon catheter|
    US11000679B2|2014-02-04|2021-05-11|Boston Scientific Scimed, Inc.|Balloon protection and rewrapping devices and related methods of use|
    WO2015119890A1|2014-02-04|2015-08-13|Boston Scientific Scimed, Inc.|Alternative placement of thermal sensors on bipolar electrode|
    US10709490B2|2014-05-07|2020-07-14|Medtronic Ardian Luxembourg S.A.R.L.|Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods|
    US9114197B1|2014-06-11|2015-08-25|Silver Bullett Therapeutics, Inc.|Coatings for the controllable release of antimicrobial metal ions|
    US9821094B2|2014-06-11|2017-11-21|Silver Bullet Therapeutics, Inc.|Coatings for the controllable release of antimicrobial metal ions|
    US8927004B1|2014-06-11|2015-01-06|Silver Bullet Therapeutics, Inc.|Bioabsorbable substrates and systems that controllably release antimicrobial metal ions|
    US9452242B2|2014-06-11|2016-09-27|Silver Bullet Therapeutics, Inc.|Enhancement of antimicrobial silver, silver coatings, or silver platings|
    JP2016163655A|2015-03-06|2016-09-08|オリンパス株式会社|Nerve stimulation device|
    US10612881B2|2017-12-01|2020-04-07|Placements Gaston Houle Inc.|Quiver securing mechanism|
    US11116561B2|2018-01-24|2021-09-14|Medtronic Ardian Luxembourg S.A.R.L.|Devices, agents, and associated methods for selective modulation of renal nerves|
    USD870227S1|2018-05-29|2019-12-17|Placements Gaston Houle Inc.|Quiver|
    USD876569S1|2018-05-29|2020-02-25|Placements Gaston Houle Inc.|Quiver|
    法律状态:
    2005-09-27| FPAY| Fee payment|Year of fee payment: 4 |
    2009-09-28| FPAY| Fee payment|Year of fee payment: 8 |
    2013-12-20| REMI| Maintenance fee reminder mailed|
    2014-05-14| LAPS| Lapse for failure to pay maintenance fees|
    2014-06-09| STCH| Information on status: patent discontinuation|Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
    2014-07-01| FP| Expired due to failure to pay maintenance fee|Effective date: 20140514 |
    优先权:
    申请号 | 申请日 | 专利标题
    US07520033|US5236413B1|1990-05-07|1990-05-07|Method and apparatus for inducing the permeation of medication into internal tissue|
    US3364893A| true| 1993-03-17|1993-03-17||
    US08/183,130|US5425703A|1990-05-07|1994-01-14|Method and apparatus for inducing the permeation of medication into internal tissue|
    US08/345,984|US5549603A|1990-05-07|1994-11-28|Method and apparatus for inducing the permeation of medication into internal tissue|
    US08/675,598|US5669874A|1990-05-07|1996-07-03|Method and apparatus for inducing the permeation of medication into internal tissue|
    US08/900,616|US5810763A|1990-05-07|1997-07-25|Method and apparatus for inducing the permeation of medication into internal tissue|
    US09/152,777|US6195583B1|1990-05-07|1998-09-14|Method and apparatus for inducing the permeation of medication into internal tissue|
    US09/748,397|US6389314B2|1990-05-07|2000-12-26|Method and apparatus for inducing the permeation of medication into internal tissue|US09/748,397| US6389314B2|1990-05-07|2000-12-26|Method and apparatus for inducing the permeation of medication into internal tissue|
    [返回顶部]